Daratumumab in the Treatment of Multiple Myeloma: Real World Evidence (2018-2024) at the a. Gemelli Polyclinic (Rome) and Comparison With Registration Studies
Real-world data therefore offer a more realistic view of the efficacy and safety of treatments because they reflect the use of drugs in everyday clinical practice, on patients who are more heterogeneous than those in trials and allow evidence to be collected more quickly and at lower cost.
Authors
- Marcello Pani (ORCID: https://orcid.org/0009-0003-4546-5952)
- Felice Musicco (ORCID: https://orcid.org/0000-0002-9388-0304)
- Elena Rossi (ORCID: https://orcid.org/0000-0001-9152-435X)
- Marco Sperandeo
- T Za
- Antonella Sabia
- Michele Favia (ORCID: https://orcid.org/0009-0004-5709-7832)
- Rina Campopiano
- Lidia Di Cerbo
- Domenico Tarantino
Institutions
- Agostino Gemelli University Polyclinic (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Hospital Pharmacy
- Published
- 2026-02-18
- DOI
- https://doi.org/10.1177/00185787261417153
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00